BioCryst Pharmaceuticals, Inc. (BCRX)
USD 6.47
(-4.71%)
USD 6.47
(-4.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 326.75 Million USD | 23.03% |
| 2022 | 264.23 Million USD | 76.27% |
| 2021 | 149.9 Million USD | 829.02% |
| 2020 | 16.13 Million USD | -63.93% |
| 2019 | 44.73 Million USD | 121.65% |
| 2018 | 20.18 Million USD | -14.06% |
| 2017 | 23.48 Million USD | -0.72% |
| 2016 | 23.65 Million USD | -48.98% |
| 2015 | 46.36 Million USD | 243.77% |
| 2014 | 13.48 Million USD | -21.74% |
| 2013 | 17.23 Million USD | -34.13% |
| 2012 | 26.16 Million USD | 33.18% |
| 2011 | 19.64 Million USD | -69.02% |
| 2010 | 63.41 Million USD | -9.47% |
| 2009 | 70.04 Million USD | 23.84% |
| 2008 | 56.56 Million USD | -20.6% |
| 2007 | 71.23 Million USD | 1046.79% |
| 2006 | 6.21 Million USD | 3990.38% |
| 2005 | 151.86 Thousand USD | -54.92% |
| 2004 | 336.9 Thousand USD | -79.38% |
| 2003 | 1.63 Million USD | -7.92% |
| 2002 | 1.77 Million USD | -84.1% |
| 2001 | 11.15 Million USD | 236.52% |
| 2000 | 3.31 Million USD | 10.52% |
| 1999 | 3 Million USD | -56.52% |
| 1998 | 6.9 Million USD | 331.25% |
| 1997 | 1.6 Million USD | 136.36% |
| 1996 | -4.4 Million USD | 30.16% |
| 1995 | -6.3 Million USD | -46.51% |
| 1994 | -4.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 91.49 Million USD | 0.17% |
| 2024 Q2 | 107.27 Million USD | 17.25% |
| 2024 Q3 | 113.85 Million USD | 6.13% |
| 2023 Q3 | 85.6 Million USD | 4.99% |
| 2023 Q1 | 67.84 Million USD | -11.95% |
| 2023 Q2 | 81.54 Million USD | 20.2% |
| 2023 FY | 325.09 Million USD | 23.03% |
| 2023 Q4 | 91.34 Million USD | 6.7% |
| 2022 FY | 264.23 Million USD | 76.27% |
| 2022 Q1 | 49.68 Million USD | 6.3% |
| 2022 Q2 | 65.28 Million USD | 31.4% |
| 2022 Q3 | 72.21 Million USD | 10.61% |
| 2022 Q4 | 77.04 Million USD | 6.7% |
| 2021 Q4 | 46.73 Million USD | 15.75% |
| 2021 FY | 149.9 Million USD | 829.02% |
| 2021 Q1 | 13.13 Million USD | 233.82% |
| 2021 Q2 | 49.61 Million USD | 277.71% |
| 2021 Q3 | 40.37 Million USD | -18.62% |
| 2020 FY | 16.13 Million USD | -63.93% |
| 2020 Q1 | 4.75 Million USD | -87.2% |
| 2020 Q2 | -24.62 Million USD | -618.03% |
| 2020 Q3 | 4.57 Million USD | 118.58% |
| 2020 Q4 | 3.93 Million USD | -14.01% |
| 2019 Q4 | 37.15 Million USD | 2014.63% |
| 2019 Q3 | 1.75 Million USD | 23.56% |
| 2019 Q1 | 4.4 Million USD | 65.51% |
| 2019 Q2 | 1.42 Million USD | -67.69% |
| 2019 FY | 44.73 Million USD | 121.65% |
| 2018 Q2 | 12.25 Million USD | 219.37% |
| 2018 FY | 20.18 Million USD | -14.06% |
| 2018 Q1 | 3.83 Million USD | 1.99% |
| 2018 Q3 | 1.43 Million USD | -88.28% |
| 2018 Q4 | 2.65 Million USD | 85.17% |
| 2017 Q3 | 7.5 Million USD | 143.84% |
| 2017 FY | 23.48 Million USD | -0.72% |
| 2017 Q1 | 9.14 Million USD | 39.99% |
| 2017 Q4 | 3.76 Million USD | -49.87% |
| 2017 Q2 | 3.07 Million USD | -66.35% |
| 2016 Q1 | 4.74 Million USD | 3.69% |
| 2016 Q4 | 6.53 Million USD | -14.29% |
| 2016 FY | 23.65 Million USD | -48.98% |
| 2016 Q3 | 7.62 Million USD | 60.08% |
| 2016 Q2 | 4.76 Million USD | 0.36% |
| 2015 Q4 | 4.57 Million USD | -52.53% |
| 2015 Q2 | 25.4 Million USD | 276.24% |
| 2015 Q1 | 6.75 Million USD | 24.97% |
| 2015 FY | 46.36 Million USD | 243.77% |
| 2015 Q3 | 9.63 Million USD | -62.06% |
| 2014 FY | 13.48 Million USD | -21.74% |
| 2014 Q4 | 5.4 Million USD | 155.13% |
| 2014 Q3 | -9.79 Million USD | -770.64% |
| 2014 Q2 | 1.46 Million USD | -56.84% |
| 2014 Q1 | 3.38 Million USD | -67.91% |
| 2013 Q1 | 3.47 Million USD | -14.84% |
| 2013 Q3 | -5.34 Million USD | -754.35% |
| 2013 Q4 | 10.55 Million USD | 297.34% |
| 2013 FY | 17.23 Million USD | -34.13% |
| 2013 Q2 | 817 Thousand USD | -76.5% |
| 2012 FY | 26.16 Million USD | 33.18% |
| 2012 Q2 | 4.21 Million USD | -65.55% |
| 2012 Q3 | -6.42 Million USD | -252.61% |
| 2012 Q4 | 4.08 Million USD | 163.55% |
| 2012 Q1 | 12.22 Million USD | 133.94% |
| 2011 Q1 | 5.43 Million USD | -67.44% |
| 2011 Q2 | 3.73 Million USD | -31.28% |
| 2011 Q3 | 5.24 Million USD | 40.54% |
| 2011 Q4 | 5.22 Million USD | -0.48% |
| 2011 FY | 19.64 Million USD | -69.02% |
| 2010 Q4 | 16.69 Million USD | 39.12% |
| 2010 FY | 63.41 Million USD | -9.47% |
| 2010 Q3 | 12 Million USD | 57.56% |
| 2010 Q1 | 25.98 Million USD | -48.39% |
| 2010 Q2 | 7.61 Million USD | -70.69% |
| 2009 Q3 | 10.54 Million USD | 120.35% |
| 2009 Q1 | 4.35 Million USD | -87.27% |
| 2009 FY | 70.04 Million USD | 23.84% |
| 2009 Q4 | 50.35 Million USD | 377.35% |
| 2009 Q2 | 4.78 Million USD | 9.82% |
| 2008 FY | 56.56 Million USD | -20.6% |
| 2008 Q4 | 34.24 Million USD | 284.98% |
| 2008 Q3 | 8.89 Million USD | 234.49% |
| 2008 Q2 | 2.65 Million USD | -75.31% |
| 2008 Q1 | 10.76 Million USD | -61.78% |
| 2007 Q3 | 20.46 Million USD | 52.21% |
| 2007 Q2 | 13.44 Million USD | 46.78% |
| 2007 Q1 | 9.15 Million USD | 337.82% |
| 2007 FY | 71.23 Million USD | 1046.79% |
| 2007 Q4 | 28.17 Million USD | 37.67% |
| 2006 Q2 | 1.55 Million USD | 102.08% |
| 2006 Q1 | 771 Thousand USD | 3594.83% |
| 2006 FY | 6.21 Million USD | 3990.38% |
| 2006 Q4 | 2.09 Million USD | 16.87% |
| 2006 Q3 | 1.79 Million USD | 14.89% |
| 2005 Q4 | 20.86 Thousand USD | -34.79% |
| 2005 Q3 | 32 Thousand USD | -44.83% |
| 2005 Q2 | 58 Thousand USD | 41.46% |
| 2005 FY | 151.86 Thousand USD | -54.92% |
| 2005 Q1 | 41 Thousand USD | 112.38% |
| 2004 Q3 | 270 Thousand USD | 24.42% |
| 2004 Q2 | 217 Thousand USD | 19.89% |
| 2004 Q4 | -331.09 Thousand USD | -222.63% |
| 2004 FY | 336.9 Thousand USD | -79.38% |
| 2004 Q1 | 181 Thousand USD | -78.4% |
| 2003 Q3 | 222 Thousand USD | -16.54% |
| 2003 Q4 | 838 Thousand USD | 277.48% |
| 2003 Q2 | 266 Thousand USD | -13.64% |
| 2003 Q1 | 308 Thousand USD | -15.04% |
| 2003 FY | 1.63 Million USD | -7.92% |
| 2002 FY | 1.77 Million USD | -84.1% |
| 2002 Q4 | 362.52 Thousand USD | -12.01% |
| 2002 Q3 | 412 Thousand USD | -10.63% |
| 2002 Q2 | 461 Thousand USD | -14.47% |
| 2002 Q1 | 539 Thousand USD | -84.24% |
| 2001 Q3 | 3.4 Million USD | -6.44% |
| 2001 FY | 11.15 Million USD | 236.52% |
| 2001 Q1 | 703 Thousand USD | 137.39% |
| 2001 Q2 | 3.63 Million USD | 416.93% |
| 2001 Q4 | 3.42 Million USD | 0.61% |
| 2000 Q3 | 244 Thousand USD | -62.52% |
| 2000 FY | 3.31 Million USD | 10.52% |
| 2000 Q4 | -1.88 Million USD | -870.57% |
| 2000 Q2 | 651 Thousand USD | -87.9% |
| 2000 Q1 | 5.37 Million USD | 5278.01% |
| 1999 Q4 | 100 Thousand USD | -50.0% |
| 1999 FY | 3 Million USD | -56.52% |
| 1999 Q3 | 200 Thousand USD | -91.67% |
| 1999 Q2 | 2.4 Million USD | 700.0% |
| 1999 Q1 | 300 Thousand USD | -40.0% |
| 1998 Q1 | 200 Thousand USD | 100.0% |
| 1998 Q4 | 500 Thousand USD | -91.8% |
| 1998 Q3 | 6.1 Million USD | 1425.0% |
| 1998 Q2 | 400 Thousand USD | 100.0% |
| 1998 FY | 6.9 Million USD | 331.25% |
| 1997 Q1 | 600 Thousand USD | 108.57% |
| 1997 FY | 1.6 Million USD | 136.36% |
| 1997 Q4 | 100 Thousand USD | -66.67% |
| 1997 Q3 | 300 Thousand USD | -81.25% |
| 1997 Q2 | 1.6 Million USD | 166.67% |
| 1996 Q2 | 1.9 Million USD | 850.0% |
| 1996 Q1 | 200 Thousand USD | 102.94% |
| 1996 FY | -4.4 Million USD | 30.16% |
| 1996 Q4 | -7 Million USD | -1850.0% |
| 1996 Q3 | 400 Thousand USD | -78.95% |
| 1995 Q1 | 400 Thousand USD | 128.57% |
| 1995 FY | -6.3 Million USD | -46.51% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1995 Q4 | -6.8 Million USD | -3500.0% |
| 1995 Q2 | 200 Thousand USD | -50.0% |
| 1994 Q1 | -800 Thousand USD | 0.0% |
| 1994 Q3 | -1.1 Million USD | 0.0% |
| 1994 Q4 | -1.4 Million USD | -27.27% |
| 1994 FY | -4.3 Million USD | 0.0% |
| 1994 Q2 | -1.1 Million USD | -37.5% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -171.221% |
| Jaguar Health, Inc. | 7.72 Million USD | -4130.334% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 49309.488% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 6535120.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 78.473% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -172.854% |
| ContextLogic Inc. | 59 Million USD | -453.815% |
| MiMedx Group, Inc. | 266.84 Million USD | -22.451% |
| MEI Pharma, Inc. | 49.32 Million USD | -562.418% |
| AlloVir, Inc. | -398 Thousand USD | 82198.241% |
| Novavax, Inc. | 639.93 Million USD | 48.94% |
| Aptorum Group Limited | -1.11 Million USD | 29413.225% |
| Ardelyx, Inc. | 106.66 Million USD | -206.345% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -35.731% |
| Psyence Biomedical Ltd. | -240.00 USD | 136146350.0% |
| Vaxcyte, Inc. | -75 Million USD | 535.668% |
| Precigen, Inc. | 106 Thousand USD | -308155.66% |
| Pharming Group N.V. | 220.1 Million USD | -48.453% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -63346.796% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -32283.647% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -197.663% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 280.119% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 63332.42% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 352.278% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 820.907% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1586.11% |
| Acelyrin, Inc. | -115 Thousand USD | 284231.304% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 57324.343% |
| Senti Biosciences, Inc. | -2.68 Million USD | 12278.569% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -7965.934% |
| AbCellera Biologics Inc. | 38.02 Million USD | -759.306% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 6910.15% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -272192.5% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -1021.738% |
| Chimerix, Inc. | 324 Thousand USD | -100749.074% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -65777.218% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 398576.829% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 1148.366% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 66512.805% |
| Elevation Oncology, Inc. | -39 Thousand USD | 837923.077% |
| Alkermes plc | 1.37 Billion USD | 76.231% |
| Fortress Biotech, Inc. | 57.85 Million USD | -464.795% |
| Fortress Biotech, Inc. | 57.85 Million USD | -464.795% |
| Agenus Inc. | 139.61 Million USD | -134.037% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1871.111% |
| Dyadic International, Inc. | 922.95 Thousand USD | -35302.624% |
| ImmuCell Corporation | 4.39 Million USD | -7332.436% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1451.451% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 407.898% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 186982.517% |
| Immix Biopharma, Inc. | -5468.00 USD | 5975794.952% |
| Incyte Corporation | 3.44 Billion USD | 90.503% |
| IO Biotech, Inc. | -756 Thousand USD | 43321.032% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 797.605% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 2546.135% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 739556.414% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 432.683% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 594192.727% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -40642.02% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 62102.087% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -1011.89% |
| NextCure, Inc. | -3.68 Million USD | 8969.463% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1615.859% |
| Onconetix, Inc. | -1.12 Million USD | 29088.746% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1227.972% |
| Opthea Limited | 21.72 Thousand USD | -1504278.453% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 570087.44% |
| PureTech Health plc | -1.6 Million USD | 20483.718% |
| Pyxis Oncology, Inc. | -2 Million USD | 16437.55% |
| Seer, Inc. | 7.02 Million USD | -4549.936% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 3251030.256% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -4051.328% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 8388.864% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -76963.915% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -213.885% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -141.556% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 437.03% |
| ChromaDex Corporation | 50.78 Million USD | -543.464% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 140940.948% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 521.082% |
| CRISPR Therapeutics AG | 240.95 Million USD | -35.606% |
| Precision BioSciences, Inc. | 40.47 Million USD | -707.351% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 432.866% |
| Innoviva, Inc. | 261.06 Million USD | -25.161% |
| Summit Therapeutics Inc. | -2.05 Million USD | 16039.073% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -7363.476% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1416.598% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 275860.184% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 228117.25% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -53553.695% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -4.17% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -12594.289% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 644071.226% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 4703.423% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 68955.641% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 3141936.538% |
| Soligenix, Inc. | 97.31 Thousand USD | -335680.128% |
| Century Therapeutics, Inc. | -10.8 Million USD | 3122.953% |
| Kura Oncology, Inc. | -849 Thousand USD | 38586.572% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 586.932% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 222379.592% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -229.922% |
| Autolus Therapeutics plc | -4.86 Million USD | 6813.602% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -689.521% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 194594.643% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -244.954% |
| GRI Bio, Inc. | 10.84 Million USD | -2914.03% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -12764.284% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 3861.379% |
| IGM Biosciences, Inc. | -211.66 Million USD | 254.375% |
| INmune Bio, Inc. | 155 Thousand USD | -210707.097% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -427.537% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 21792.422% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 50489.233% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 1116281.595% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -81181.343% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 16470.291% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 104493.291% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -245.911% |
| Verastem, Inc. | -62 Thousand USD | 527117.742% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -13318.932% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 125291.954% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -10694.549% |
| Histogen Inc. | 3.76 Million USD | -8569.435% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -56609.981% |
| Surrozen, Inc. | -27.23 Million USD | 1299.967% |
| Organovo Holdings, Inc. | -5.38 Million USD | 6163.296% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 27218.966% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1374.032% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1529.518% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 16502675.758% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -5286.222% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 486836.381% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -111.092% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -224009.053% |
| Apollomics, Inc. | 127 Thousand USD | -257184.252% |
| Amarin Corporation plc | 165.54 Million USD | -97.384% |
| Mesoblast Limited | -9.81 Million USD | 3429.098% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1879.589% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 395.732% |
| Synaptogenix, Inc. | -6347.00 USD | 5148217.221% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 640788.235% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -102.492% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 81.41% |
| Better Therapeutics, Inc. | -2.72 Million USD | 12073.287% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 391.323% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 3.351% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2864326.858% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 5319.665% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 29590.162% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -4365.031% |
| Insmed Incorporated | 239.63 Million USD | -36.354% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -9032.225% |
| OmniAb, Inc. | 14.66 Million USD | -2127.797% |
| Alector, Inc. | -95.05 Million USD | 443.757% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -160.109% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 851.791% |
| Zai Lab Limited | 170.9 Million USD | -91.191% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -299.075% |
| Aura Biosciences, Inc. | -1.29 Million USD | 25331.737% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -251246.923% |
| Immunic, Inc. | -111 Thousand USD | 294470.27% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1961.0% |
| Veracyte, Inc. | 248.14 Million USD | -31.676% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 104.675% |
| FibroGen, Inc. | 128.9 Million USD | -153.484% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 57934674.468% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2900.67% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 90.386% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -83897.686% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 8.047% |
| TG Therapeutics, Inc. | 219.1 Million USD | -49.128% |
| Galecto, Inc. | -830 Thousand USD | 39467.59% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 23692.13% |
| Fortrea Holdings Inc. | 424 Million USD | 22.936% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 479.207% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 57728.042% |
| XBiotech Inc. | -1.74 Million USD | 18835.722% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 29590.162% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 803.129% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 532.588% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -345.147% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1844.599% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 16.011% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 758.149% |
| Vaxxinity, Inc. | -2.23 Million USD | 14726.276% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2985.514% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -1236.35% |
| NexImmune, Inc. | -1.02 Million USD | 31979.017% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -6050844.444% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 4698.464% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.109% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 489050.574% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 9301.662% |
| Ainos, Inc. | -253.73 Thousand USD | 128877.494% |
| Pluri Inc. | 322 Thousand USD | -101375.466% |
| Prothena Corporation plc | -129.2 Million USD | 352.901% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -548.008% |
| Celularity Inc. | 6.75 Million USD | -4737.172% |
| Rallybio Corporation | -150 Thousand USD | 217934.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 1102.089% |
| MeiraGTx Holdings plc | 287 Thousand USD | -113750.523% |
| Omeros Corporation | -69.77 Million USD | 568.266% |
| Humacyte, Inc. | -76.55 Million USD | 526.847% |
| Immunocore Holdings plc | 248.39 Million USD | -31.547% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 2254.071% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -423.791% |
| Blueprint Medicines Corporation | 236.58 Million USD | -38.112% |
| CalciMedica, Inc. | -58 Thousand USD | 563463.793% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 23013.815% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -1024.595% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 11589.135% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 1158.646% |
| Pulmatrix, Inc. | -8.22 Million USD | 4075.073% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 28027.436% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 81992.481% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 181.935% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -11672.329% |
| Cytokinetics, Incorporated | -322.59 Million USD | 201.289% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -37801.532% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 95921.408% |
| Vor Biopharma Inc. | -3.49 Million USD | 9457.131% |
| Roivant Sciences Ltd. | 109.23 Million USD | -199.127% |
| Evogene Ltd. | 1.39 Million USD | -23256.04% |
| ProKidney Corp. | -3.16 Million USD | 10410.855% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 844.104% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -4665.218% |
| CorMedix Inc. | -205.56 Thousand USD | 159054.962% |
| BioLineRx Ltd. | 1.1 Million USD | -29390.162% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 515.339% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 990254.545% |
| Atai Life Sciences N.V. | -5000.00 USD | 6535120.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 268238.586% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 340465.625% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 23624.19% |
| Sagimet Biosciences Inc. | 2 Million USD | -16237.55% |
| MediciNova, Inc. | 979.7 Thousand USD | -33251.978% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 487.518% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 345667.13% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1676.925% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -33.621% |
| Biomea Fusion, Inc. | -4.2 Million USD | 7877.934% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 62.543% |
| Mereo BioPharma Group plc | 7.42 Million USD | -4300.094% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 105503.548% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2723025.0% |
| Absci Corporation | -41.84 Million USD | 880.786% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 6535120.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 527.836% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 13377.164% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -52.877% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 34823.804% |
| Allakos Inc. | -6.14 Million USD | 5420.811% |
| Imunon, Inc. | -720 Thousand USD | 45481.768% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 573.58% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 31.34% |
| BioAtla, Inc. | -103.73 Million USD | 414.998% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2864326.858% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 183667.978% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 234.566% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 105164.63% |
| XOMA Corporation | 3.86 Million USD | -8362.859% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 566.221% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -2108.672% |
| aTyr Pharma, Inc. | -2.38 Million USD | 13783.04% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -2522.4% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 1126827.586% |
| Viridian Therapeutics, Inc. | -1 Million USD | 32515.774% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -2513469130.769% |
| Akari Therapeutics, Plc | -4000.00 USD | 8168875.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 48.696% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -167715.909% |
| UroGen Pharma Ltd. | 73.35 Million USD | -345.456% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1324.062% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -2814292.765% |
| Orgenesis Inc. | -5.72 Million USD | 5807.441% |
| Entera Bio Ltd. | -56 Thousand USD | 583583.929% |
| GH Research PLC | -315 Thousand USD | 103830.476% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 172984.127% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 62338.286% |
| Xencor, Inc. | -85.26 Million USD | 483.241% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 147966.52% |
| Replimune Group, Inc. | -2.65 Million USD | 12407.006% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 32734.763% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -83.729% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -167715.909% |
| Portage Biotech Inc. | -54 Thousand USD | 605194.444% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 345667.13% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 86771.353% |
| OncoCyte Corporation | 413 Thousand USD | -79016.465% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 7269310.234% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 147185235.135% |
| Purple Biotech Ltd. | -196 Thousand USD | 166809.694% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -3543.521% |
| scPharmaceuticals Inc. | 9.78 Million USD | -3240.329% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 3228.314% |
| HilleVax, Inc. | -2.15 Million USD | 15255.427% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 336956.701% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 2177859.264% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 49014.82% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1420756.522% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 4353204.65% |
| Savara Inc. | -44.26 Million USD | 838.22% |
| Curis, Inc. | 9.81 Million USD | -3230.456% |
| Daré Bioscience, Inc. | 2.76 Million USD | -11698.101% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 261944.889% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 18998.265% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 143411.842% |
| BeiGene, Ltd. | 2.07 Billion USD | 84.282% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 11786.791% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 181.756% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -476.402% |
| Erasca, Inc. | -3.73 Million USD | 8855.386% |
| bluebird bio, Inc. | -4.03 Million USD | 8207.965% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1158052.371% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 82.842% |
| DBV Technologies S.A. | 15.72 Million USD | -1977.511% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1158052.371% |
| Moderna, Inc. | 2.15 Billion USD | 84.838% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 35810.492% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -3981.327% |
| Molecular Templates, Inc. | 50.39 Million USD | -548.38% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 61061.007% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -144.23% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 5351.543% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 930.519% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 394.031% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 9206.773% |
| MacroGenics, Inc. | 50.52 Million USD | -546.686% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 5458.331% |
| Prime Medicine, Inc. | -147.9 Million USD | 320.92% |
| Aditxt, Inc. | -111.66 Thousand USD | 292730.306% |
| Adagene Inc. | 18.11 Million USD | -1704.109% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -66857.172% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -133.057% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -107.019% |
| SciSparc Ltd. | 2.19 Million USD | -14779.372% |
| Vericel Corporation | 135.57 Million USD | -141.009% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1304547.283% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 1054747.86% |
| Generation Bio Co. | -73.91 Million USD | 542.087% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 74871.396% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -498.237% |
| Invivyd, Inc. | -2.02 Million USD | 16211.982% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 208.613% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 315990.678% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -239.066% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -232.442% |
| ADMA Biologics, Inc. | 88.21 Million USD | -270.39% |
| Clene Inc. | 533 Thousand USD | -61204.128% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -1255.297% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 34243.26% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1676.925% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -16336.167% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 168254.449% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -556.061% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 4707.318% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 39185.048% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -291.717% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -446818.427% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -514.633% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 288.668% |
| Trevena, Inc. | 1.45 Million USD | -22357.113% |
| Surrozen, Inc. | -27.23 Million USD | 1299.967% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 92664.023% |
| Cingulate Inc. | -582.91 Thousand USD | 56154.368% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 1054135.484% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1758.719% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 4316493.659% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 37188.649% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 51.998% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 33171.964% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 580042.139% |
| Kronos Bio, Inc. | 1.37 Million USD | -23715.671% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 708.86% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 112001.027% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 67014.117% |
| ImmunityBio, Inc. | -17.89 Million USD | 1926.445% |
| Korro Bio, Inc. | -3.63 Million USD | 9101.405% |
| Kineta, Inc. | 5.43 Million USD | -5914.191% |
| BioVie Inc. | -229.37 Thousand USD | 142551.51% |
| Codexis, Inc. | 57.33 Million USD | -469.908% |
| Celularity Inc. | 6.75 Million USD | -4737.172% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -8042.312% |
| Celcuity Inc. | -142.77 Thousand USD | 228962.102% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -645780.609% |
| Cibus, Inc. | 1.42 Million USD | -22878.27% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 87466.578% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1525.677% |
| IN8bio, Inc. | -2.5 Million USD | 13164.814% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1359.302% |
| Annexon, Inc. | -3.26 Million USD | 10101.561% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 16085.861% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 882.881% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -50954.844% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 58.029% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -88.923% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 17297.421% |
| Arcellx, Inc. | 108.27 Million USD | -201.768% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 1109.457% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -312.544% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1644.776% |
| Moolec Science SA | -143.3 Thousand USD | 228110.886% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 872.132% |
| Geron Corporation | -123.5 Million USD | 364.569% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -9840.706% |
| Royalty Pharma plc | 1.79 Billion USD | 81.785% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 566.188% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 9046362.458% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -141111.629% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 393.276% |
| Humacyte, Inc. | -76.55 Million USD | 526.847% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 34524.774% |
| 89bio, Inc. | -273 Thousand USD | 119789.011% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 26094.511% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 38631.958% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 265751.22% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -29100.268% |
| Notable Labs, Ltd. | 113 Thousand USD | -289060.177% |
| Liquidia Corporation | 14.6 Million USD | -2138.021% |
| Mustang Bio, Inc. | -2.22 Million USD | 14785.438% |
| Immunovant, Inc. | -231 Thousand USD | 141550.649% |
| Quantum-Si incorporated | 488 Thousand USD | -66857.172% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 688.115% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 1089270.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -17448.389% |
| Acasti Pharma Inc. | -11 Thousand USD | 2970563.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 159789.078% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 50489.233% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 295.061% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -28699.291% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 85861.417% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 16787.998% |
| PepGen Inc. | -1.18 Million USD | 27697.213% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 257384.252% |
| United Therapeutics Corporation | 2.07 Billion USD | 84.215% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1527.047% |
| Solid Biosciences Inc. | -76.56 Million USD | 526.774% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 395763.756% |
| Immuneering Corporation | -764.13 Thousand USD | 42860.732% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -493004.853% |
| Belite Bio, Inc | -399 Thousand USD | 81992.481% |
| XOMA Corporation | 3.86 Million USD | -8362.859% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1730.82% |
| Bionomics Limited | -434.44 Thousand USD | 75310.439% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 30523.743% |
| uniQure N.V. | 2.21 Million USD | -14651.738% |
| Cassava Sciences, Inc. | -89.42 Million USD | 465.399% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 454.898% |
| Forte Biosciences, Inc. | -9000.00 USD | 3630666.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 39231.856% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 74871.396% |
| Altimmune, Inc. | -65.37 Million USD | 599.826% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 9.745% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 30523.743% |
| Compugen Ltd. | 31.45 Million USD | -938.789% |
| Peak Bio, Inc. | 367.76 Thousand USD | -88746.803% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -1232.807% |
| Benitec Biopharma Inc. | 108 Thousand USD | -302447.222% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 419011.538% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 27261.347% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 18033.644% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 274680.672% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 27261.347% |
| Instil Bio, Inc. | -4.75 Million USD | 6970.29% |
| argenx SE | 1.1 Billion USD | 70.523% |
| Immunome, Inc. | -8.9 Million USD | 3768.474% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 17388.413% |
| Verona Pharma plc | -679.62 Thousand USD | 48178.202% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 186814.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 13800.252% |
| CervoMed Inc. | -1.29 Million USD | 25358.517% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 13675.031% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 6940.088% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -13123.432% |
| Moolec Science SA | -143.3 Thousand USD | 228110.886% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 80180.141% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 12330.866% |
| AnaptysBio, Inc. | 14.78 Million USD | -2110.615% |
| Design Therapeutics, Inc. | -537 Thousand USD | 60947.486% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 76622.482% |
| NeurAxis, Inc. | 2.15 Million USD | -15050.48% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -15126.048% |
| Lumos Pharma, Inc. | 2 Million USD | -16180.568% |
| Achilles Therapeutics plc | -4.73 Million USD | 7006.205% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 186814.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 309303.691% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -932.103% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -37801.532% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 31761.919% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 817.377% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -759786.047% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 39850.73% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 2483387.734% |
| Palisade Bio, Inc. | 246 Thousand USD | -132725.61% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 990254.545% |
| Beam Therapeutics Inc. | -59.67 Million USD | 647.578% |
| Neurogene Inc. | -3.26 Million USD | 10116.891% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -134.507% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 8950.244% |
| Sesen Bio, Inc. | 40 Million USD | -716.878% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 110117.172% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 8213.931% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 3515.754% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -2220.675% |
| Athira Pharma, Inc. | -969 Thousand USD | 33820.433% |
| Vaccinex, Inc. | -16 Million USD | 2141.683% |
| HCW Biologics Inc. | -574.82 Thousand USD | 56943.66% |
| XOMA Corporation | 3.86 Million USD | -8362.859% |
| Nektar Therapeutics | 53.47 Million USD | -511.001% |
| Arvinas, Inc. | 71.8 Million USD | -355.085% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 491.501% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 620.511% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 101575.466% |
| Rezolute, Inc. | -36 Thousand USD | 907741.667% |
| Clene Inc. | 533 Thousand USD | -61204.128% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 25447997.196% |
| BeyondSpring Inc. | 1.75 Million USD | -18560.822% |
| Synlogic, Inc. | -1.92 Million USD | 17082.9% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 883210.811% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 5260.313% |
| Peak Bio, Inc. | 367.76 Thousand USD | -88746.803% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1823.098% |
| Krystal Biotech, Inc. | 47.6 Million USD | -586.38% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -131.589% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -6402.507% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 12719.674% |
| MannKind Corporation | 136.19 Million USD | -139.921% |
| Ikena Oncology, Inc. | -50.49 Million USD | 747.134% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -200.284% |
| Gossamer Bio, Inc. | -4.38 Million USD | 7551.562% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 129763.095% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 6535120.0% |
| Legend Biotech Corporation | 140.92 Million USD | -131.855% |
| Mural Oncology plc | -2.56 Million USD | 12828.905% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 59401.452% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 326851.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1474.4% |
| REGENXBIO Inc. | 53.02 Million USD | -516.174% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 6199.568% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 169951.072% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 18965.531% |
| Vaxart, Inc. | -60.76 Million USD | 637.747% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 124443.938% |
| Cellectis S.A. | 18 Thousand USD | -1815183.333% |
| Longeveron Inc. | 221 Thousand USD | -147751.131% |
| Repare Therapeutics Inc. | -80.07 Million USD | 508.082% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 70.105% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 25351.236% |
| Revolution Medicines, Inc. | -399.66 Million USD | 181.756% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 933674.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -666738.776% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 96.204% |
| Denali Therapeutics Inc. | -93.34 Million USD | 450.047% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1304547.283% |
| Veru Inc. | 7.56 Million USD | -4218.717% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 216491.391% |
| Cingulate Inc. | -582.91 Thousand USD | 56154.368% |
| Passage Bio, Inc. | -3.72 Million USD | 8881.268% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 2713077.416% |
| Exicure, Inc. | -1.42 Million USD | 23062.122% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 85413.577% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -11988.457% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 63834.53% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -379.627% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 218506.224% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 651.888% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -83468.031% |
| OmniAb, Inc. | 14.66 Million USD | -2127.797% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1534.327% |
| Lipocine Inc. | -2.85 Million USD | 11561.658% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 17829.3% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 5827.45% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 21792.422% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -333.84% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 502793.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -287.623% |
| Ocugen, Inc. | -33.53 Million USD | 1074.3% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 10433.681% |
| Q32 Bio Inc. | 578 Thousand USD | -56431.315% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 123402.264% |
| Alumis Inc. Common Stock | -1.28 Million USD | 25547.897% |
| Equillium, Inc. | 35.95 Million USD | -808.702% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 19241.828% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -65161.575% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 7904091.292% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 126258.687% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -77198.728% |
| Dominari Holdings Inc. | 2.03 Million USD | -15925.061% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 178194.086% |
| vTv Therapeutics Inc. | -13.59 Million USD | 2503.465% |
| Bio-Techne Corporation | 773.07 Million USD | 57.734% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1786.662% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 29.088% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 28051.326% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1462.598% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -2693.46% |
| Nkarta, Inc. | -5.86 Million USD | 5667.405% |
| BioCardia, Inc. | -7.24 Million USD | 4607.532% |
| Iterum Therapeutics plc | -1.75 Million USD | 18771.486% |